One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...

Vector-borne diseases (VBDs) represent a critical challenge in infectious disease control due to their complex transmission dynamics, diverse vector ...

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...

The 2026 Priestley Medalist and Nobel laureate struggled with finding her way through school before achieving the greatest feats in science ...

EDEN (short for environmentally-derived evolutionary network) processes evolutionary DNA from more than one million newly ...

A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance. In a potential breakthrough for tackling antibiotic resistance, researchers from the ...

The most promising path for scalably small refrigeration is with semiconductors called transverse thermoelectrics, but current models of their electronic behavior cannot explain their experimentally ...

CRISPR-Cas genetic engineering of plants holds tremendous potential for providing food security, battling biotic and abiotic crop stresses caused by climate change, and for environmental remediation ...

Last year’s landmark case of “Baby KJ”—the first patient to receive a personalized CRISPR‑based gene therapy—showcased both the promise and the persistent challenges of genome editing. While CRISPR ...

ROCHESTER — Vyriad, a growing Rochester firm, recently raised an additional $25 million in funding to fuel its “race” to bring a new technology to market that accurately targets cancer within a ...

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...